50 Milk Street Boston,
United States of America
- Phone: (646) 853-5797
Qynapse Inc. is a medical technology company commercializing an AI-powered and proprietary neuroimaging software platform that creates the potential for earlier clinical precision on the frontlines of central nervous system (CNS) disorders, such as Alzheimer's, Parkinson's and Multiple Sclerosis. Qynapse’s flagship solution, QyScore®, FDA-Cleared and CE-Marked, combines MRI scans and artificial intelligence to produce rapid, actionable insights into CNS disorders, adding the potential for more precise and objective brain scan analysis. Qynapse's predictive AI technology, QyPredict®, powered by machine learning algorithms and available for research-use-only, has the potential to predict disease trajectory and improve targeted patient selection in clinical trials. Qynapse is headquartered in France, in the United States and in Canada. Join us at RSNA 2021: visit our booth #4161 in the AI Showcase area (South Hall Level 3) and join us during our AI Theater live presentation on November 30th 2pm CST – to know more about Qynapse and our solutions.
Create or Log in to My Show Planner to add notes.